Paul Matteis
Managing Director, Head of Therapeutics Research
Biotechnology
Boston
matteisp@stifel.com | (617) 488-4485 | v-Card | View CoveragePaul Matteis is Head of the Therapeutics Research Team. He joined Stifel in 2018 as a Managing Director and Senior Analyst. From 2019 to 2023, Paul was repeatedly named a “Runner Up” in Small/Mid Cap Biotechnology, and a "Rising Star" in both 2015 and 2016 by Institutional Investor as part of the publication's All-America Research Team rankings.
Prior to joining Stifel, Paul was a Senior Biotechnology Analyst covering small-cap and mid-cap companies at Leerink, with a focus on neuroscience, central nervous system, and rare disease. He received a B.A. in Psychology from Skidmore College in New York, where he graduated Phi Beta Kappa, after which he worked in a sleep research laboratory at Harvard Medical School.